Antonio Maestri - Publications

Pathological and Clinical Implications of Tumor Microenvironment Evaluated With Multiplex Immunohistochemistry in Testicular Embryonal Carcinoma.

Journal: Clinical genitourinary cancer

Published: June 05, 2025

Long term outcomes of breast primary sarcomas and malignant phyllodes tumors: 20 years observational analysis of the BEAM∗ study group. (∗the breast European association for mesenchymal tumors).

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: April 24, 2025

Safety and efficacy analysis of neoadjuvant pertuzumab, trastuzumab and standard chemotherapy for HER2-positive early breast cancer: real-world data from NeoPowER study.

Journal: BMC cancer

Published: March 03, 2024

First-line treatment of metastatic castration-resistant prostate cancer: the real-world Italian cohort of the Prostate Cancer Registry.

Journal: Tumori

Published: April 11, 2022

Iatrogenic Ocular Surface Diseases Occurring during and/or after Different Treatments for Ocular Tumours.

Journal: Cancers

Published: February 26, 2021

Effective Containment of a COVID-19 Subregional Outbreak in Italy Through Strict Quarantine and Rearrangement of Local Health Care Services.

Journal: Open forum infectious diseases

Published: October 27, 2020

Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer.

Journal: Therapeutic advances in medical oncology

Published: September 29, 2020

Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy.

Journal: Future oncology (London, England)

Published: May 22, 2020

The Role of Nutrition and Nutritional Supplements in Ocular Surface Diseases.

Journal: Nutrients

Published: March 11, 2020

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study.

Journal: Immunotherapy

Published: February 25, 2020

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.

Journal: Journal of translational medicine

Published: May 30, 2019

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study.

Journal: Immunotherapy

Published: October 18, 2018